Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole pre-treatment for hypermicrofilaremic loiasis in Gabon
ISRCTN14889921Phase 2Completed
- Sponsor
- Université des Sciences de la Santé
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of albendazole in loiasis (3 arms), sponsored by Université des Sciences de la Santé. Primary endpoint: Day 30 Adequate Clinical and Parasitological Response (ACPR). Started Nov 2022; status: completed.
02
Drugs
albendazole
03
Conditions
loiasis
Beyond the preview
Go deeper on ISRCTN14889921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14889921.